Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × Inotuzumab Ozogamicin × Clear all

NCT00867087 2017-12-05

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Phase 2 Completed

64 enrolled 15 charts

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse